PL3589298T3 - Mezenchymalne komórki macierzyste pochodzące z galarety whartona do leczenia sepsy - Google Patents

Mezenchymalne komórki macierzyste pochodzące z galarety whartona do leczenia sepsy

Info

Publication number
PL3589298T3
PL3589298T3 PL18712945.7T PL18712945T PL3589298T3 PL 3589298 T3 PL3589298 T3 PL 3589298T3 PL 18712945 T PL18712945 T PL 18712945T PL 3589298 T3 PL3589298 T3 PL 3589298T3
Authority
PL
Poland
Prior art keywords
wharton
stem cells
mesenchymal stem
treating sepsis
jelly mesenchymal
Prior art date
Application number
PL18712945.7T
Other languages
English (en)
Inventor
Danièle BENSOUSSAN
Sébastien GIBOT
Loïc REPPEL
Caroline LAROYE
Amir BOUFENZER
Léonore AVERCENC
Céline HUSELSTEIN
Original Assignee
Université De Lorraine
Centre Hospitalier Régional Universitaire De Nancy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université De Lorraine, Centre Hospitalier Régional Universitaire De Nancy filed Critical Université De Lorraine
Publication of PL3589298T3 publication Critical patent/PL3589298T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL18712945.7T 2017-02-28 2018-02-28 Mezenchymalne komórki macierzyste pochodzące z galarety whartona do leczenia sepsy PL3589298T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1751649 2017-02-28
PCT/FR2018/050472 WO2018158542A1 (fr) 2017-02-28 2018-02-28 Cellules souches mesenchymateuses issues de la gelée de wharton pur le traitement du sepsis

Publications (1)

Publication Number Publication Date
PL3589298T3 true PL3589298T3 (pl) 2022-10-24

Family

ID=59070788

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18712945.7T PL3589298T3 (pl) 2017-02-28 2018-02-28 Mezenchymalne komórki macierzyste pochodzące z galarety whartona do leczenia sepsy

Country Status (11)

Country Link
US (2) US11963984B2 (pl)
EP (2) EP3589298B1 (pl)
JP (2) JP7248984B2 (pl)
CN (1) CN110520138A (pl)
AU (1) AU2018228352B2 (pl)
CA (1) CA3054588A1 (pl)
DK (1) DK3589298T3 (pl)
ES (1) ES2927203T3 (pl)
PL (1) PL3589298T3 (pl)
PT (1) PT3589298T (pl)
WO (1) WO2018158542A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4155389A3 (en) * 2020-03-31 2023-07-12 Cell Exosome Therapeutics Inc. Method of producing proliferated cells, method of producing cell product, mesenchymal stem cell population and method of producing same, culture supernatant of stem cells and method of producing same, and therapeutic agent
FR3131860B1 (fr) 2022-01-14 2024-05-17 Steminov Dispositif pour la manipulation et le traitement d’objets biologiques et procédé d’utilisation
CN115089611A (zh) * 2022-06-28 2022-09-23 北京三有利康细胞科技有限公司 一种cd146+或cd146-脐带间充质干细胞亚群在制备防治脓毒症的产品中的应用
CN116083353B (zh) * 2022-12-02 2025-10-17 唐颐生物医学(天津)有限公司 一种过表达Anxa1的脐带间充质干细胞外泌体及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0814249D0 (en) 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
WO2011101834A1 (en) * 2010-02-22 2011-08-25 Advanced Neuro-Science Allies Private Limited A method for obtaining mesenchymal stem cells, media, methods and composition thereof
DK2576768T3 (en) 2010-06-01 2017-08-28 Auxocell Laboratories Inc NATIVE WHARTONS JELLY STEM CELLS AND CLEANING THEREOF
CA2829586C (en) * 2011-03-11 2021-03-02 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
TW201534724A (zh) * 2013-06-12 2015-09-16 Shiseido Co Ltd 間葉系幹細胞之低氧培養法
CN103352026B (zh) * 2013-07-24 2016-08-10 黑龙江天晴干细胞股份有限公司 人脐带血富血小板裂解液培养自体脐带间充质干细胞方法
PH12015000014A1 (en) * 2014-06-24 2016-10-17 Stempeutics Res Pvt Ltd Methods of upscaling mesenchymal stromal cell production, compositions and kit thereof
WO2016001846A1 (en) 2014-06-30 2016-01-07 Tigenix S.A.U. Mesenchymal stromal cells for treating sepsis
CN104666347B (zh) * 2015-02-28 2019-08-09 广州医科大学附属第一医院 脐带间充质干细胞在制备治疗肺间质纤维化的药物制剂中的应用
RU2604672C1 (ru) 2015-06-05 2016-12-10 Федеральное государственное бюджетное учреждение "Гематологический научный центр" Министерства Здравоохранения Российской Федерации (ФГБУ "ГНЦ" МЗ РФ) Способ лечения септического шока в состоянии агранулоцитоза
US20170296588A1 (en) * 2016-04-19 2017-10-19 AngioStem, Inc. Mesenchymal stem cells derived from placental sources
CN105861430B (zh) * 2016-04-29 2019-07-23 南京大学 一种外泌体、外泌体的制备方法及其在制备治疗脓毒症药物或者制剂中的应用

Also Published As

Publication number Publication date
ES2927203T3 (es) 2022-11-03
EP4091618A1 (fr) 2022-11-23
CN110520138A (zh) 2019-11-29
US11963984B2 (en) 2024-04-23
AU2018228352A1 (en) 2019-09-26
WO2018158542A8 (fr) 2018-10-11
JP2023060299A (ja) 2023-04-27
US20240245732A1 (en) 2024-07-25
EP3589298B1 (fr) 2022-06-22
EP3589298A1 (fr) 2020-01-08
PT3589298T (pt) 2022-09-22
CA3054588A1 (en) 2018-09-07
JP7248984B2 (ja) 2023-03-30
DK3589298T3 (da) 2022-09-26
AU2018228352B2 (en) 2024-08-01
WO2018158542A1 (fr) 2018-09-07
US20200000856A1 (en) 2020-01-02
JP2020508679A (ja) 2020-03-26

Similar Documents

Publication Publication Date Title
IL287553B1 (en) Modified pluripotent cells
EP3307864A4 (en) CELLAR HOLDER FOR AUTOLOGOUS CELL THERAPY
PT3551748T (pt) Células estaminais do mesênquima derivadas de tecido perinatal: método de preparação e suas utilizações
WO2016164896A3 (en) Modulation of smn expression
IL261623A (en) Stem cells expressing mesenchymal and neuronal markers, compositions containing them and methods for their preparation
IL255480B (en) Preparations containing mesenchymal stem cells and their uses
SG11202107732XA (en) Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
PL3589298T3 (pl) Mezenchymalne komórki macierzyste pochodzące z galarety whartona do leczenia sepsy
PL3569238T3 (pl) Mezenchymalne komórki macierzyste z trombiną do leczenia noworodkowej hie
EP3584302A4 (en) COKE DRY TEMPER INSTALLATION
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
EP3300506A4 (en) Use of mesenchymal stem cells in treating osteoarthritis
PL3675879T3 (pl) Cerebrolizyna do zastosowania w leczeniu cadasil
GB202012452D0 (en) Improvements in or relating to carriers
GB201805287D0 (en) Haematoietic stem cell treatment
GB202019880D0 (en) Geoengineering constructions for use in railways
IL281574A (en) Human pluripotent adult stem cells
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
HUP1900405A1 (hu) Hipoklórossavas sterilizáló vizes összetétel
PL3377089T3 (pl) Kompozycje zawierające cdnf do zastosowania do donosowego leczenia chorób ośrodkowego układu nerwowego
ZA201801788B (en) Lysobactin for use in the treatment of bovine mastitis
SG11201901985XA (en) Keratin fiber treatment composition
SG10202002971SA (en) Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells
GB201916448D0 (en) Improvements in or relating to deodorant sticks
GB201916395D0 (en) Improvements in or relating to deodorant sticks